DUEXIS (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug
Therapeutic Advances in Musculoskeletal Disease,  Clinical Article

Bello AE – The combination of ibuprofen and famotidine in a single tablet has the potential to improve adherence to gastroprotective therapy in patients who require Nonsteroidal anti–inflammatory drug (NSAID) treatment and the use of a histamine type 2 receptor antagonist rather than a proton–pump inhibitor may decrease the risk for clinically significant drug interactions and adverse events (e.g. interaction with clopidogrel, fracture, pneumonia, Clostridium difficile infection).

Methods
  • DUEXIS (ibuprofen 800 mg, famotidine 26.6 mg) is a proprietary combination, immediate release tablet containing 800 mg of ibuprofen and 26.6 mg of famotidine.
  • The efficacy of DUEXIS taken three times daily has been demonstrated in two large–scale controlled clinical trials (Registration Endoscopic Studies to Determine Ulcer Formation of HZT–501 Compared with Ibuprofen: Efficacy and Safety Studies (REDUCE) and REDUCE–2) which showed that this new formulation significantly reduced the risk of endoscopic upper gastrointestinal ulcers compared with ibuprofen alone (REDUCE–1, p < 0.0001, REDUCE–2, p <0.05).

Results
  • DUEXIS was also superior to ibuprofen in decreasing the risk for gastric ulcers (REDUCE–1, p < 0.001, REDUCE–2, p < 0.05) as well as duodenal ulcers (REDUCE–1, p < 0.05, REDUCE–2, p < 0.05).
  • Safety results from these two studies indicated that treatment–emergent adverse events occurred in 55% of patients treated with DUEXIS versus 58.7% for ibuprofen, and serious adverse events were recorded for 3.2% of patients treated with DUEXIS versus 3.3% of those on ibuprofen.
  • Adverse events leading to discontinuation occurred in 6.7% of patients treated with DUEXIS and 7.6% for ibuprofen.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pain Management

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pain Management Articles

1 Transforaminal versus parasagittal interlaminar epidural steroid injection in low back pain with radicular pain: a randomized, double-blind, active-control trial Full Text Pain Physician, July 23, 2014    Free full text

2 Radiofrequency ablation for chronic low back pain: A systematic review of randomized controlled trials Pain Research and Management, October 6, 2014    Clinical Article

3 Effectiveness of duloxetine compared with pregabalin and gabapentin in diabetic peripheral neuropathic pain The Clinical Journal of Pain, September 23, 2014    Clinical Article

4 Efficacy of dry needling for treatment of myofascial pain syndrome Journal of Back and Musculoskeletal Rehabilitation, October 22, 2014    Review Article

5 Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010 JAMA Internal Medicine, October 2, 2014    Clinical Article

6 Human umbilical cord mesenchymal stem cell transplantation for the treatment of chronic discogenic low back pain Full Text Pain Physician, July 23, 2014    Free full text

7 Treatment of common low back pain: A new approach to an old problem Pain Practice, June 25, 2014    Clinical Article

8 Disc extrusions and bulges in nonspecific low back pain and sciatica: Exploratory randomised controlled trial comparing yoga therapy and normal medical treatment Journal of Back and Musculoskeletal Rehabilitation, October 1, 2014    Evidence Based Medicine

9 Efficacy of the McKenzie method in patients with chronic nonspecific low back pain: A protocol of randomized placebo-controlled trial Physical Therapy, October 8, 2014    Clinical Article

10 Spinal cord stimulation for the treatment of chronic back pain patients: 500-Hz vs. 1000-Hz burst stimulation Neuromodulation: Technology at the Neural Interface, October 28, 2014    Clinical Article

11 Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial Journal of Pain and Symptom Management, October 29, 2014    Clinical Article

12 Effect of vitamin D on musculoskeletal pain and headache: A randomized, double-blind, placebo-controlled trial among adult ethnic minorities in Norway Pain, September 26, 2014    Clinical Article

13 Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: a meta-analysis Acta Anaesthesiologica Scandinavica, October 24, 2014    Review Article    Clinical Article

14 Lumbar fusion versus nonoperative management for treatment of discogenic low back pain: A systematic review and meta-analysis of randomized controlled trials Journal of Spinal Disorders & Techniques, June 30, 2014    Evidence Based Medicine    Review Article    Clinical Article

15 Sugammadex reduces postoperative pain after laparoscopic bariatric surgery: A randomized trial Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, October 7, 2014    Clinical Article

16 Efficacy of memantine in the treatment of fibromyalgia: a double-blind randomised controlled trial with 6-month follow-up Pain, September 16, 2014    Clinical Article

17 Conservative treatments for lumbar radicular pain Current Pain and Headache Reports, September 19, 2014    Review Article

18 Intradiskal methylene blue treatment for diskogenic low back pain PM&R, August 6, 2014    Clinical Article

19 Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization Pain Medicine, October 13, 2014    Clinical Article

20 Opioids versus physical therapy for management of chronic back pain Full Text The Journal for Nurse Practitioners , September 26, 2014    Free full text    Clinical Article

Indexed Journals in Pain Management: more

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close